Equity Overview
Price & Market Data
Price: $1.75
Daily Change: +$0.24 / 13.71%
Daily Range: $1.75 - $1.75
Market Cap: $1,235,941,552
Daily Volume: 1,648
Performance Metrics
1 Week: 15.89%
1 Month: 15.89%
3 Months: 6.06%
6 Months: 16.67%
1 Year: 94.44%
YTD: -5.41%
Details
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.